• Search results for mild
Image Title
IE19SEPT120_07-11-2019_12_44_44_02264418

IIT Madras research shows efficacy of Indomethacin in treating hospitalised mild, moderate COVID-19 patients

The study conducted at Panimalar Medical College and Research Institute was led by Dr Rajan Ravichandran, an Adjunct Faculty at IIT Madras

Published on 22nd April 2022
PTIIPHOTOS293_01033965

Since the pandemic broke out, PGIMER has reported over 2.3k cases. This is the status now 

Already struggling due to inadequate staff to cater to the patient load, the high positivity rate among staffers is an additional worry for PGIMER

Published on 8th January 2022
amu1200

AMU VC Prof Tariq Mansoor tests positive with mild symptoms

It may be recalled that in the second wave of the COVID-19 pandemic, Aligarh Muslim University had lost over 30 teachers 

Published on 6th January 2022

Study finds that majority of Indians experience mild or no side effects post COVID-19 vax

According to the study, 70 per cent of Indians after taking the first dose of Covishield and 64 per cent with Covaxin experienced no or mild side effects

Published on 25th August 2021
Ventilator_covid_hospital_PTI_1200_010521

Monoclonal antibody therapy is safe, helps prevent serious illness for transplant patients with mild COVID, finds study

The study is important because transplant patients who are infected with COVID-19 have a higher risk of severe illness and death

Published on 10th June 2021
jamia1

Jamia Hamdard sets up COVID care centre on campus to tackle mild to moderate cases amid spike in numbers

This is not the first centre set up by Jamia Hamdard, they had set up two others earlier with the help of Delhi Police to combat the rising numbers in Delhi

Published on 27th May 2021
covid

Study finds that mild COVID-19 induces life-long antibody protection

The researchers noted that immune cells could persist for a lifetime, churning out antibodies all the while

Published on 25th May 2021
COVID-19

Mild COVID very unlikely to cause lasting heart damage: Study

The researchers said that the findings should reassure the public, as they relate to the vast majority of people who had Covid-19

Published on 8th May 2021
ministry-of-ayush_1533501815

Indigenous herbal medicines helpful in treating mild to moderate COVID-19, claims AYUSH Ministry

The Ministry of Ayush in collaboration with the Council of Scientific and Industrial Research (CSIR) recently completed a multi-central clinical trial to evaluate the safety and efficacy of Ayush-64

Published on 8th May 2021
coronavirus-drugs

Is Sotrovimab the new treatment for mild COVID cases? European Medicines Agency seeks authorisation

Sotrovimab is a monoclonal antibody, a lab-produced antibody that is intended to stimulate the immune system by reducing the ability of the coronavirus's spike protein to enter the body's cells

Published on 7th May 2021
COVIDKIOSK9

Antiviral drug 'Clevira' repurposed for treating mild to moderate COVID-19 patients

The drug is effective when taken orally and the dosage is one tablet twice daily after food for 14 days. The drug has also proved to be safe on liver and kidney parameters

Published on 30th April 2021
ministry-of-ayush_1533501815

AYUSH-64 drug useful in treating mild to moderate COVID-19 cases: AYUSH ministry

Addressing a virtual press conference, Arvind Chopra, director, Centre for Rheumatic Diseases, Pune, said the trial of the drug in this direction was conducted at three centres

Published on 29th April 2021
2021_4largeimg_180098466

Health Ministry releases revised guidelines for home isolation of mild COVID-19 cases

In case of falling oxygen saturation levels or shortness of breath, the person should require hospital admission and seek immediate consultation with the treating physician or surveillance team

Published on 29th April 2021
MDSJAN2021852

One in four people experience mild systemic side effects from COVID-19 vaccines: Study

While rates of side effects were much lower than expected from clinical trials, rates of infection after vaccine were reassuring after two three weeks

Published on 28th April 2021
school_children_pti_picture

Nasal COVID-19 vaccine will be easy to administer to school-going children with mild viral load: AIIMS director

Once children start going to the school regularly and they contract the COVID-19 infection, they will not have much problem but if they bring it home they can spread it to their family members

Published on 20th January 2021

Search results 1 - 15 of 17